NovoCure Limited has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $300 million in an initial public offering of common shares.
The company did not specify the number of shares to be sold and the pricing.
The company said it has applied...
Opexa Therapeutics, Inc. (OPXA) will present at the Sidoti Emerging Growth Conference in Times Square, New York.
The event is scheduled to begin at 10:40 AM ET, September 2, 2015.
To access the live webcast, log on at www.opexatherapeutics.com